View live AXSOME THERAPEUTICS INC chart to track its stock's price action. Latest stock price today and the US's most active stock market forums. CPRX, and AUPH. people own Axsome Therapeutics on Robinhood on December. 19 Mar 2019 Aurinia Pharmaceuticals Inc. (AUPH) SEC Filing 40-F Annual report for the key executives include the granting of stock options that vest over time, is the founder of RenalPro, a moderated forum for renal professionals.

Get today's Aurinia Pharmaceuticals Inc stock price and latest AUPH news as well as Aurinia Pharma real-time stock quotes, technical analysis, full financials and more. Get today's Aurinia Pharmaceuticals Inc stock price and latest AUPH news as well as Aurinia Pharma real-time stock quotes, technical analysis, full financials and more. 12/10/2019 · Aurinia Pharmaceuticals (AUPH) prices public offering of 11.12M common shares at $15/share for gross proceeds of $166.7M. Closing date is December 12, 2019 Aurinia Pharmaceuticals historical price data and AUPH charts. Free real-time prices, trades, and chat. Aurinia Pharmaceuticals (AUPH) stock price, charts, trades & the US's most popular discussion forums.

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development of a therapeutic drug to treat autoimmune diseases in Canada. The company's lead drug includes Voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis.

Aurinia Pharmaceuticals stock quote and AUPH charts. Latest stock price today and the US's most active stock market forums. Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more. Find the latest AURINIA PHARMACEUTICALS INC (AUP.TO) stock discussions in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. 11/30/2017 · Patent extension issues have been and continue to be an invalid bear thesis for Aurinia. Why Aurinia is putting VOS up against Restasis over XIIDRA despite Get today's Aurinia Pharmaceuticals Inc stock price and latest AUPH news as well as Aurinia Pharma real-time stock quotes, technical analysis, full financials and more. Get today's Aurinia Pharmaceuticals Inc stock price and latest AUPH news as well as Aurinia Pharma real-time stock quotes, technical analysis, full financials and more.

ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures.

Aurinia Pharmaceuticals Inc. Message board - Online Community of active, educated investors researching and discussing Aurinia Pharmaceuticals Inc. Stocks.

9 Feb 2018 It has been one of Dr. KSS's most highly recommended stocks, though he.. I was reading some AUPH discussions on other forums and 

AUPH stock rating and analysis - Aurinia Pharmaceuticals : a summary of key financial strength and profitability metrics. 26 Nov 2019 What happened Shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) were up 14% at 3:35 p.m. EST on Tuesday as investors anticipated the  The Wall Street of Stock Trading and Investing Financial Community Site for Traders and Investors. Free stock Forum - Aurinia Pharmaceuticals Inc - AUPH. The Wall Street of Stock Trading and Investing Financial Community Site for Traders and Investors. Free stock Forum - Aurinia Pharmaceuticals Inc - AUPH. 4 Dec 2019 A 357-subject Phase 3 clinical trial evaluating Aurinia Pharmaceuticals' (AUPH) lead drug voclosporin, See all stocks on the move ».

Implied Volatility Surging For Aurinia Pharmaceuticals (AUPH) Stock Options By Zacks Investment Research - Oct 16, 2017. Investors in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 20, 2017 $5 Call had some of the

12/10/2019 · Aurinia Pharmaceuticals (AUPH) prices public offering of 11.12M common shares at $15/share for gross proceeds of $166.7M. Closing date is December 12, 2019

Get today's Aurinia Pharmaceuticals Inc stock price and latest AUPH news as well as Aurinia Pharma real-time stock quotes, technical analysis, full financials and more. Get today's Aurinia Pharmaceuticals Inc stock price and latest AUPH news as well as Aurinia Pharma real-time stock quotes, technical analysis, full financials and more.